Silencing salusin-β reduces NOX2 expression and ROS production, which in turn alleviates OS, NFκB activation, and inflammation, thereby mitigating cardiac dysfunction in DCM. The gene discussed is CYBB; the disease is familial dilated cardiomyopathy.